Shuttle Pharmaceuticals Net Income Over Time
| SHPH Stock | USD 1.11 0.08 7.77% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Shuttle Pharmaceuticals Performance and Shuttle Pharmaceuticals Correlation. Is there potential for Biotechnology market expansion? Will Shuttle introduce new products? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Shuttle Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Shuttle Pharmaceuticals and related stocks such as Kaleido Biosciences, Innovation1 Biotech, and Xeno Transplants Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XENO | (46.7 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (256.4 K) | (230.7 K) | (242.3 K) |
| SYVC | (2.9 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (4 M) | (3.6 M) | (3.8 M) |
Shuttle Pharmaceuticals and related stocks such as Kaleido Biosciences, Innovation1 Biotech, and Xeno Transplants Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Shuttle Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Shuttle Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Shuttle Pharmaceuticals | SHPH |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 401 Professional Drive, |
| Exchange | NASDAQ Exchange |
USD 1.11
Check out Shuttle Pharmaceuticals Performance and Shuttle Pharmaceuticals Correlation. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Shuttle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.